Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis
Primary Purpose
Osteoarthritis of the Hand
Status
Approved for marketing
Phase
Locations
Study Type
Expanded Access
Intervention
Diclofenac
Sponsored by
About this trial
This is an expanded access trial for Osteoarthritis of the Hand
Eligibility Criteria
Inclusion Criteria:
- diagnosed osteo or rheumatoid arthritis
- Oral NSAIDs were not deemed appropriate treatment
- Completed diclofenac sensitivity patch test with negative result
- Signed informed consent form
Exclusion Criteria:
- At the discretion of the physician and HPB
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT01579890
First Posted
April 16, 2012
Last Updated
April 17, 2012
Sponsor
Mallinckrodt
Collaborators
Nuvo Research Inc.
1. Study Identification
Unique Protocol Identification Number
NCT01579890
Brief Title
Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis
Official Title
A Non-blinded, Non-placebo Controlled, Compassionate Use, Open Treatment, Open-ended Program of the Safety of Pennsaid Topical Lotion (Diclofenac) in the Treatment of Osteo or Rheumatoid Arthritis
Study Type
Expanded Access
2. Study Status
Record Verification Date
April 2012
Overall Recruitment Status
Approved for marketing
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mallinckrodt
Collaborators
Nuvo Research Inc.
4. Oversight
5. Study Description
Brief Summary
This was a compassionate use, open treatment safety study of Pennsaid topical lotion (diclofenac) for osteo or rheumatoid arthritis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis of the Hand
7. Study Design
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Diclofenac
Intervention Description
diclofenac topical lotion
10. Eligibility
Sex
All
Eligibility Criteria
Inclusion Criteria:
diagnosed osteo or rheumatoid arthritis
Oral NSAIDs were not deemed appropriate treatment
Completed diclofenac sensitivity patch test with negative result
Signed informed consent form
Exclusion Criteria:
At the discretion of the physician and HPB
12. IPD Sharing Statement
Learn more about this trial
Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis
We'll reach out to this number within 24 hrs